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INTRODUCTION
The world has changed over the last 30 years: urban-
ization, ageing and globalized lifestyle changes com-
bine to make chronic and non-communicable diseases 
– including depression, diabetes, cardiovascular disease 
and cancers – and injuries increasingly important causes 
of morbidity and mortality. The growing prevalence of 
chronic diseases and population aging – are placing a 
heavy burden on health systems, individuals, families, 
businesses and governments. The World Health Orga-
nization (WHO) estimates that an increase of 10% of 
chronic diseases is associated with a reduction of 0.5% 
of annual economic growth [1]. On other hand, in the 
light of scientific and technical developments, people 
live for longer. The children born with complex con-
ditions are now living to adulthood, while those with 
learning disabilities and other groups have lifelong 
needs. All these people need continuous care and sup-
port, and the right systems and resource to enable that. 
In addition, the renewed socio-economic, cultural and 
epidemiological conditions have undermined health 
systems, highlighting the weaknesses of the traditional 
way of understanding and organizing the health system. 
In fact, although health systems are also a reflection of 
a globalizing consumer culture, however do not provide 
an adequate response to need and demand, and that 
they are driven by interests and goals that are discon-
nected from people’s expectations. In fact, the tradi-
tional approaches to care focus on individual diseases 
and are based on a relationship between an individual 
health/social care service-user and a single health/social 
care professional. Then, current health systems amplify 
the potential for care fragmentation between different 
professionals and care organisations. 
Thus, the increasingly complex and multidimensional 
care request, combined with the presence of increas-
ingly aware and demanding patients, accentuates the 
need for new strategies to rationalize resources, orga-
nizational methods and use of services, which preserve 
economic sustainability by acting on waste and on in-
efficiencies. In this scenario, the identification of inte-
gration mechanisms reveals an essential condition for 
ensuring continuity of care. 
MATERIALS AND METHODS
The paper reviews the main literature available on the 
integration of heal services and relates it to rare diseas-
es. Several medical databases and additional informa-
tion resources were utilised and included government 
documents, reports from international bodies such as 
the World Health Organisation, EURORDIS and aca-
demic studies. The key search terms were integration 
of care and rare diseases, from 2000 through January 
2018. Articles of interest were reviewed to determine 
which were relevant and subjected to analysis. Selected 
papers were later used to extrapolate the most relevant 
messages about integration of healthcare services for 
rare diseases. 
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Abstract
The increasingly complex and multidimensional care request, combined with the pres-
ence of increasingly aware and demanding patients, accentuates the need for new strate-
gies to preserve health systems economic sustainability. Therefore, integration mecha-
nisms reveal an essential condition for ensuring continuity of care. The paper reviews the 
main literature available on the integration of heal services and relates it to rare diseases. 
The literature identifies several system levers for the effective design and implementation 
of integrated care frameworks, namely: political support and commitment, governance, 
stakeholder engagement, organisational change, leadership, collaboration and trust, 
workforce education and training, patient empowerment, financing and incentives, ICT 
infrastructure and solutions, monitoring and evaluation system.
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RESULTS
The importance of integration is emphasized by the 
WHO global strategy on people-centred and integrated 
health services. The strategy calls for shifting the way 
health services are funded, managed and delivered, and 
proposes five interdependent strategic directions that 
need to be adopted for health services to become more 
people-centred and integrated (Figure 1). The five inter-
dependent strategic directions include: 
1.  empowering and engaging people; 
2.  strengthening governance and accountability;
3.  reorienting the model of care;
4.  coordinating services;
5.  creating an enabling environment.
Our review highlighted that there is no unifying 
definition or common conceptual understanding of 
integrated care, which is most likely a result of “the 
polymorphous nature of integrated care itself” [2]. The 
concept of integrated care is strongly shaped by per-
spectives and expectations of various users in the health 
system, making a unified definition difficult. 
“Integrated care” is a term that reflects a concern 
to improve patient experience and achieve greater ef-
ficiency and value from health delivery systems. The 
aim is to address fragmentation in patient services, and 
enable better coordinated and more continuous care. 
In effect, the perspectives that construct the concept 
are likely to be shaped by views and expectations of 
various stakeholders in the health system. The literature 
reviewed offers a range of examples of how integrated 
care might be adopted in practice. 
The rarity and complexity of rare diseases highly con-
dition the availability of knowledge about their impact 
on patients’ and families’ life expectancy, daily life and 
autonomy. Indeed, patients affected by a particular rare 
disease are few and spread geographically. It is there-
fore clear that RD have special requirements which dis-
tinguish them from other complex or chronic diseases. 
They are not only complex but also frequently unpre-
dictable, requiring often stays in hospital, specialist care 
and access to professional and medical knowledge not 
always available or may not even exist. The knowledge 
on the impact of rare diseases on patients’ functionality 
remains a challenge within the national systems, which 
often entails an inadequate recognition and inappro-
priate compensation for disabilities, exacerbating the 
social and economic vulnerability of people living with 
a rare disease and of their families. Several studies, con-
ducted by patient’s organisations, have demonstrated 
the serious impact of rare diseases. Results of the first 
European-wide survey on the everyday impact of rare 
diseases – “Juggling care and daily life: the balancing 
act of the rare disease community” [3], conducted by 
EURORDIS survey initiative, Rare Barometer Voices 
and involving 3000 patients and carers [4, 5] – put into 
evidence the serious impact of rare diseases and the 
need for integrated care. 
DISCUSSION
The WHO global strategy on people-centred and in-
tegrated health services identified five strategic direc-
tions. 
Put together, the five strategic directions represent 
an interconnected set of actions that seeks to trans-
form health systems to provide services that are more 
people-centred and integrated. However, for each spe-
cific context, the exact mix of strategies that will be 
used needs to be designed and developed, taking into 
account local contexts, values and preferences. The 
benefits of a people-centred and integrated approach 
are well documented: increased delivery efficiency, de-
creased costs, improved equity in uptake of service, bet-
ter health literacy and self-care, increased satisfaction 
with care, improved relationships between patients and 
their care providers, and an improved ability to respond 
to health-care crises [6]. Recognizing that health sys-
tems are highly context-specific, it is clear that there 
is no a single model of people-centred and integrated 
health, instead several strategic directions to better co-
ordinate care around people’s needs. In view of litera-
ture reviews, it’s clear that establishing integrated care 
is a multifaceted and long-term process, due also to the 
difficulties in showcasing the causality between the de-
livery of integrated care and outcomes. 
There are many reasons for this. Firstly, in the con-
text of integrated care it is not possible to effectively 
separate multicomponent strategies that are needed to 
achieve results. Secondly, the criteria for assessing the 
success of integrated care models are not necessarily 
specific or measurable. Lastly, there are few opportuni-
ties for making comparisons with alternative models or 
control cases. However, there does appear to be some 
guidance on the first steps required to make change 
happen; specifically, development of a common vision 
should be based on a clear articulation of the popula-
tion’s needs in local communities, which then can de-
velop into a shared strategy for change. The identifica-
tion of population needs, therefore, should be a starting 
point in developing any integrated care strategy. It is 
clear that even these first steps for integrated care re-
quire careful planning and that the process of change 
needs strong leadership and good management support 
Empowering and engaging people
Strengthening
governance
and accountability
Reorienting the model of care
Coordinating
services
Creating an
enabiling
environment
Figure 1
Five interdependent strategic directions to support people-
centred and integrated health services (Reproduced with kind 
permission from WHO – WHO Global Strategy on People-cen-
tred and Integrated Health Services; 2015 [6]). 
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[7]. In other words, it’s required a paradigm shift in 
policy action and a genuine commitment to engaging 
with communities in the attainment and protection of 
their health. 
Since integrated care is strongly shaped by perspec-
tives and expectations of various users in the health 
system, success of each solution is to depend on the 
context in which the integration is introduced, not just 
the initiative itself.
The conceptualization of integrated care is multidi-
mensional and encompasses four key elements: a) the 
types of integration (e.g., functional, organisational, 
etc.); b) the breadth of integration (i.e., vertical or hori-
zontal); c) the degree of integration; and d) the process 
of integration (i.e., structural, cultural, social) [2]. A re-
cent review of the literature on integrated care revealed 
some 175 definitions and concepts [8]. The most com-
mon definition of integration comes from the World 
Health Organization: “The organization and manage-
ment of health services so that people get the care they 
need, when they need it, in ways that are user friendly, 
achieve the desired results and provide value for mon-
ey”. This reinforces the fact that integration is a means 
to an end, not an end in itself. 
WHO suggests a common set of principles, that pro-
vide a unifying values framework [6]. The core prin-
ciples of people-centred and integrated health services 
are: 
• Comprehensive – offering care that is comprehensive 
and tailored to the evolving health needs and aspira-
tions of people and populations, with a commitment 
to universal health coverage. 
• Equitable – providing care that is accessible and avail-
able to all. 
• Sustainable – delivering care that is efficient, effective 
and contributes to sustainable development. 
• Coordinated – ensuring that care is integrated around 
people’s needs and effectively coordinated across dif-
ferent providers and settings. 
• Continuous – providing care and services across the 
life course. 
• Holistic – focusing on physical, socioeconomic, men-
tal and emotional well-being. 
• Preventive – tackling the social determinants of ill-
health through action within and between sectors 
that promotes public health and health promotion. 
• Empowering – supporting people to manage and take 
responsibility for their own health. 
• Goal oriented – in terms of how people make health 
care decisions, assess outcomes and measure success. 
• Respectful – of people’s dignity, social circumstances 
and cultural sensitivities. 
• Collaborative – supporting relationship-building, 
team-based working and collaborative practice across 
primary, secondary and tertiary care, and with other 
sectors. 
• Co-produced – through active partnerships with peo-
ple and communities at an individual, organizational 
and policy-level. 
• Endowed with rights and responsibilities – that all 
people should expect, exercise and respect. 
• Governed through shared accountability – of care 
providers to local people for the quality of care and 
health outcomes. 
• Evidence-informed – so that policies and strategies 
are guided by the best available evidence and sup-
ported over time through the assessment of measur-
able objectives for improving quality and outcomes. 
• Led by whole-systems thinking – that views the health 
system as a whole and tries to understand how its 
component parts interact with each other and how 
the system is influenced by factors beyond it. 
• Ethical – by making sure that care optimizes the 
risk–benefit ratio in all interventions, respects the 
individual’s right to make autonomous and informed 
decisions, safeguards privacy, protects the most vul-
nerable and ensures the fair distribution of resources. 
Contextualizing integrating care to the field of rare 
diseases, it is important to underline that Rare diseases 
(RD) are heterogeneous in terms of prevalence, age 
of onset, clinical severity and outcome. However, they 
share various common features: they are often serious, 
chronic, progressive, degenerative and associated with 
co-morbidities. Rare diseases (RD) are heterogeneous 
in terms of prevalence, age of onset, clinical severity 
and outcome. However, they share various common 
features: they are often serious, chronic, progressive, 
degenerative and associated with co-morbidities. For 
most RD there isn’t a specific treatment available and 
existing treatments are not always able to minimize all 
the complex impairments generated by the disease. 
Even when RD are not associated with a disability, will 
in many cases influence the person’s health condition 
and impact on daily life in a disabling way [4]. 
To resolve this problem, some Member States are 
developing specific project to improve the knowledge 
and visibility of disabilities associated with RDs, and to 
provide tools to help the stakeholders. In France, for 
instance, Orphanet (the international database and 
portal on RDs and orphan drugs) is currently working 
on describing the functional consequences of each rare 
disease, having developed the Orphanet Functioning 
Thesaurus, derived and adapted from the International 
Classification of Functioning, Disability and Health – 
Children and Youth [9, 10]. According to surveys car-
ried out by EURORDIS [4, 5]: 
• 65% of respondents have to visit different health, so-
cial and local services in a short period of time; 
• 67% feel that these services communicate badly be-
tween each other; 
• 7 in 10 find that organising care is time-consuming 
and 6 in 10 find it hard to manage; 
• 7 in 10 do not feel well informed about their rights; 
• 7 in 10 reduce or stop their professional activity due 
to the disease and the care burden. 
These everyday challenges result in significant loss of 
income and financial difficulties, often compounded by 
the need to relocate to another home adapted to their 
health needs or situated closer to the health or social 
services. Moreover, people living with a rare disease feel 
that they face discrimination in leisure activities (32%), 
education (30%) and daily activities (29%). 32% of pa-
tients also felt discriminated in the labour market, ei-
ther when searching for a job (17%) or at their current 
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job (15%) [11]. Then, in the particular context of rare 
diseases, including the challenges in regards to diagno-
sis, feelings of exclusion and lack of treatment generate 
a considerable moral suffering and burn out situations 
are frequent among patients and family members.
Hence it is clear that, although providing holistic 
support to any given patient is certainly an added chal-
lenge, the rare diseases are likely to benefit consider-
ably from integrated care that bridges professions and 
knowledge bases. On the other hand, as early as 2008, 
the European Commission and Council recognized the 
need for coordination of care provided to people living 
with a rare disease, nationally and internationally, rec-
ommending Member States to [12, 13]: 
• establish and implement plans or strategies for rare 
disease in order to aim to ensure that patients with 
rare diseases have access to high-quality care, within 
the framework of their health and social systems; 
• organise healthcare pathways for people living with 
a rare disease through the establishment of coop-
eration with relevant experts, and exchange of pro-
fessionals and expertise within the country or from 
abroad when necessary; 
• encourage Centres of Expertise to be based on a mul-
tidisciplinary approach to care when addressing rare 
diseases; 
• gather national expertise on rare diseases and support 
the pooling of that expertise with European counter-
parts in order to support: (a) the sharing of best prac-
tices on diagnostic tools and medical care as well as 
education and social care in the field of rare diseases. 
EUROPLAN, the European Project for Rare Diseas-
es National Plans Development (www.europlanproject.
eu) played a crucial role in these activities. This project 
promotes a “double level” approach: respectful of na-
tional decisions but also intended to ensure a coher-
ent and consistent progress in EU rare diseases care. 
In fact, trough EUROPLAN Recommendations [14] 
provided tools to Member States for developing a plan 
or strategy, linking it to a common framework at the 
European level. These recommendations and report of 
several national conferences [15] recommended taking 
into account the need for social inclusion, psychologi-
cal and educational development for people living with 
rare, chronic and debilitating diseases. It’s been also 
recognized the instrumental role of social services to 
the empowerment, the wellbeing and health of people 
living with a rare disease. Several adopted national plans 
include specific measures to facilitate coordination be-
tween health and social and support services. Various 
countries have already started to implement some of 
these approaches. 
In 2016, the European Commission has reiterated 
and strengthened its position adopting “The Commis-
sion Expert Group Recommendations to Support the 
Incorporation of Rare Diseases into Social Services and 
Policies”, and sustaining clearly the need to promote 
measures that facilitate multidisciplinary, holistic, con-
tinuous, person-centred and participative care provi-
sion to people living with rare diseases. In the holistic 
and person-centred approach, social services play a fun-
damental role to achieve a high level of social protec-
tion, health protection, gender equality, and economic, 
social and territorial cohesion. In fact, they should help 
people to participate fully in all aspects of life and to 
maintain own independence, in order to increase qual-
ity of life. To achieve these goals, social services should 
be closely interlinked with health services, educational 
services. 
These documents, sided by other recent policy devel-
opments at European and national levels, represent an 
important policy step into approaching rare diseases’ 
complex challenges in regards to holistic care provision 
[16]. 
Innovative approaches aiming at bridging the gap 
between health, social and community service and sup-
port providers are currently being developed and test-
ed in different European countries: standards of care, 
networks of expertise, case management services, one-
stop-shop services, amongst others.
The EU-funded project INNOVCare has also de-
veloped a factsheet with input from all stakeholders 
to highlight why integrated care is needed for rare dis-
eases. This factsheet states that Integrated care ensures 
that people living with a rare disease and their carers: 
• overcome the care burden that they face and secure 
the services and support that they require; 
• achieve a quality of life on an equal footing with other 
citizens; 
• participate in society and in the job market to their 
highest potential; 
• fully realize their fundamental human rights. 
The challenge of providing holistic care to people liv-
ing with a rare disease is huge and requires multidisci-
plinary teams, involvement of all stakeholders as well as 
change of perspectives, of care provision concepts and 
of services. The organization of holistic care pathways 
at national level is essential to overcome this challenge. 
At national level, centers of expertise play an important 
role: are responsible for gathering and coordinating 
knowledge and care and – as such –- should promote 
the cooperation with other care providers, including 
social services and other local services. In France, 23 
National Health Networks for Rare Diseases (Filière 
de Santé Maladies Rares) have been created by the 
Ministry of Health to coordinate actions between dif-
ferent stakeholders involved in care provision to people 
living with rare diseases. The mission of these Networks 
consists of reducing the diagnosis and therapeutic 
wavering; facilitating the entry and orientation in the 
care pathway; implementing actions in the social field 
(in collaboration with the National Solidarity Fund for 
Autonomy), targeted at improving social care and al-
location of disability compensatory benefits. Specific 
actions are defined according to needs of the diseases 
covered by the network and inter-networks actions are 
also developed, for instance, a working group has been 
set up to improve education, pathway at school and 
care taking at school [16]. 
An excellent example of integrated care is also found 
in Resource Centres for Rare diseases, which have re-
cently gathered in the European Network of Resource 
Centres – RareResourceNet. RareResourceNet aims at 
accelerating the development and the implementation 
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of holistic high quality care pathways for people living 
with a rare disease across Europe, contributing to raise 
standards of care and support. 
Resource centres for rare diseases are a one-stop shop 
service, complementary to health and social care ser-
vices, specifically designed for people living with a rare 
disease and their carers. They provide holistic services 
and support, while also creating a bridge between pa-
tients and families and various stakeholders, services 
and professionals providing health care, social care, 
and social support – including rehabilitation, education 
and employment. They thus empower service provid-
ers, professionals, patients and carers to overcome the 
challenges of rare diseases. Moreover, they advocate for 
the adoption of holistic and integrated care services and 
policies in European countries. 
An example of a resource centre for rare diseases is 
the NoRo Pilot Reference Center for Rare Diseases, in 
Romania, set up in 2011, through a project implement-
ed in partnership with Frambu Norway (www.frambu.
no) and funded by Norway Grants. This offers a social 
service and a medical service, which provides holistic 
care based on a multidisciplinary and complementary 
approach and on the individual assessment of patients’ 
needs. The centre ensures continuity of care through a 
one-stop-shop style of service, specifically designed for 
people living with a rare disease, combining medical, 
social and educational service. The integration of social 
services through setting up one-stop-shop services has 
the potential to generate cost efficiency, effectiveness 
of the delivery and capacity to tackle complex and mul-
tiple problems while also ensuring take-up and coverage 
[17]. 
Another resource that is being promoted as guaran-
tee of integrated care is the “case manager”. To date, in 
most rare disease cases, the role of the case manager is 
assumed by patients or family members, without having 
sufficient information regarding care, the health and so-
cial system and relevant contacts. This situation is very 
burdensome for people living with a rare disease and 
their families. Family members – often the main car-
ers – frequently find themselves in burn out situations, 
unable to cope physically and psychologically with the 
situation. Therefore, professional case managers are 
crucial in relieving the care burden faced by people liv-
ing with a rare disease and their families. 
These professionals represent an element that can 
ensure that there is a better coordination in the care 
pathway of people living with a rare disease, function-
ing as a link between the health and the social needs of 
the patient, particularly in very complex situations, due 
to the course of care and the need for the intervention 
of multiple structures and professionals. Case manag-
ers have an instrumental role in supporting patients and 
families as well as professionals. 
The EU-funded INNOVCare project (www.innov-
care.eu) has developed and outline for the role of case 
manager, with the input of all stakeholders involved in 
care delivery and decision making on care for people 
living with a rare disease [18]. According to this outline, 
case managers should: 
• act as a single and stable point of contact; 
• listen, inform, support and empower patients and 
families; 
• asses and monitor patients’ and families’ needs; 
• provide holistic, patient-centred care planning & care 
co-ordination; 
• act as a hub of information and knowledge; 
• inform, support and empower care professionals; 
• facilitate coordination between services/networks of 
services; 
• help to prevent risks and to limit use of health ser-
vices, when these may not be needed; 
• develop working methods that support patient/fami-
lies empowerment. 
The INNOVCare project is also the testing use 
of case managers in the context of rare diseases, and 
should bring to light more information on the impact of 
this type of service on care provision and on the quality 
of life of patients and families. Main goal of this project 
is collect data on unmet social needs of people living 
with a rare disease and their families in the EU, analyse 
existing social care pathways in a selection of Member 
States in order to facilitate the creation of a European 
network of resource centres to ensure exchange of good 
practices. 
Another example can be found in The Netherlands, 
where case management for an individual with a rare 
disease is often divided into organisational and medi-
cal components. For help regarding the organisational 
aspects of care as such, the “case manager” is a nurse-
practitioner who is in close contact with the responsible 
clinician. For medical issues only, there is the so-called 
physician-manager, who coordinates the multidisci-
plinary care and is the immediate contact for medical 
questions. This physician, having a broad overview of 
the disease and its health and psychosocial impact, can 
refer the patient to other professional care-givers within 
the network of expertise or outside of it for paramedical 
care or other types of services [16]. 
Lastly, European Reference Networks (ERNs) and 
their constituent healthcare providers are also key ac-
tors in facilitating integrated care for rare diseases, in 
accordance with recommendations adopted by EU-
CERD and by the Commission Expert Group on Rare 
Diseases. ERNs can support integrated care by for ex-
ample follow a multi-disciplinary approach and func-
tioning as a platform to share experiences and good 
practice. Centres of expertise, on their hand, can co-
ordinate within the specialised healthcare sector mul-
tidisciplinary competences/skills, including paramedical 
skills and social services. They also can provide educa-
tion and training to non-healthcare professionals (such 
as school teachers, personal/homecare facilitators) as 
well as contribute to and provide accessible informa-
tion adapted to the specific needs of patients and their 
families, of health and social professionals. Discussions 
on the roles of ERNs in supporting integrated care can 
also be found in the report of the Joint RD-Action and 
INNOVCare workshop on “Creating a Sustainable En-
vironment for Holistic & Innovative Care for Rare Dis-
eases & Complex Conditions” (April 2018). This work-
shop also highlights several other important topics, case 
studies and good practices on integrated and holistic 
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care for rare diseases, which are available for download 
online on the project website. 
CONCLUSIONS 
Various methods are currently being used to promote 
integrated care for rare diseases and there are yet sev-
eral challenges to fully address this issue. However a 
review of experiences in implementing integrated care 
in Europe has identified elements of good practices 
deemed to be successful and which potentially could 
be transferable across Europe. Were identified several 
inter-related “building blocks” or “system levers” for the 
effective design and implementation of integrated care 
frameworks [19, 20]. These relate to: 
1. Political support and commitment. System-wide 
transformative change can only happen when many pol-
icy levers are aligned and activated towards shared goals. 
2. Governance. Establishing strong governance mecha-
nisms at both national and local level and among all ser-
vice providers, care authorities and actors involved is an 
essential step in configuring integrated care models. 
3. Stakeholder engagement. The broader the ambition, 
the more numerous and diverse are the stakeholders 
that should be engaged; effective communication strat-
egies establish trust, confidence and good collaboration 
and involvement of all stakeholders. 
4. Organisational change. The provision of integrated 
care and service redesign implies changes in the health-
care structures, organisation of workflows, workforce 
development and resource allocation to provide more 
responsive care delivery. 
5. Leadership. Effective national leadership and the 
emergence of local leaders are important factors in 
managing the complex process of transformation and 
implementation of integrated care solutions. 
6. Collaboration and trust. The broad set of changes 
needed to deliver integrated care presents a significant 
challenge that can be partially overcame by the willing-
ness to collaborate and put the interest of the overall 
care system above individual incentives. 
7. Workforce education and training. The implementa-
tion of integrated care solutions often requires the re-
design of health and social care professionals’ roles and 
the creation of new roles to ensure continuity of care. 
8. Patient focus/empowerment. The patient is a mem-
ber of the “care team”: he or she must be involved in 
the decision-making processes, and care plans need to 
be tailored to patients’ individual needs. 
9. Financing and incentives. Different funding models 
can support the transition to the time when the new 
integrated services are fully operational and the older 
ones are decommissioned. 
10. ICT infrastructure and solutions. Integrated care re-
quires the sharing of health information across diverse 
providers to enable continuous collaboration and citi-
zens’ active involvement. 
11. Monitoring/evaluation system. The establishment 
of monitoring and performance evaluation systems is 
essential to provide evidence of the impact on quality of 
care, cost of care, access and citizen experience. 
To date, the evidence base for the benefits of integrat-
ed care on both patient outcomes and cost effective-
ness is based yet on small-scale examples, although the 
scale of implementation is slowly growing. Better, more 
comparable and longer term data collection and report-
ing will be crucial for building a more comprehensive 
evidence base. 
Promoting integrated care and bridging the gaps be-
tween health and social care for rare diseases is not only 
necessary but crucial to increase the life expectancy, 
quality of life and autonomy of people. For this reason, 
to guide future policies integrated assistance, it’s rec-
ommended that: 
• information on ongoing pilot projects/case studies and 
good practices is consolidated and widely dissemi-
nated: the long term impact assessment of the pilot 
care provisions is essential to support robust evidence 
based decision making on integrated care, as the im-
pact on quality of life and the return on investment 
are hardly short term outcomes; research on econom-
ic evaluation of the integrated care, should consider 
the economic long term impact beyond the healthcare 
and service provision onto a society level: taking into 
account the consequences of the impact of integrated 
care provision on patients’ and carers’ health, wellbe-
ing, autonomy and financial burden [16]; 
• the evaluation of impact uses a suitable comprehen-
sive set of outcome indicators that take into account 
both the evaluation of impact of healthcare and social 
services’ interventions as well as the personal quality 
of life outcomes for patients, their families and carers; 
• patients and families are directly engaged in the design 
and implementation of these innovative solutions.
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